PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials
- PMID: 28616307
- PMCID: PMC5465155
- DOI: 10.21037/jtd.2017.04.38
PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials
Conflict of interest statement
Conflicts of Interest: Research grant (to Sripal Bangalore)—Abbott Vascular, NHLBI; Advisory board and honorarium (to Sripal Bangalore)—Abbott Vascular, Pfizer, AstraZeneca, Medicines Co, Daiichi Sankyo, Merck, Abbott.
Comment on
-
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Lancet. 2016. PMID: 27810312 Clinical Trial.
References
-
- Goetz RH, Rohman M, Haller JD, et al. Internal mammary-coronary artery anastomosis. A nonsuture method employing tantalum rings. J Thorac Cardiovasc Surg 1961;41:378-86. - PubMed
-
- Takaro T, Hultgren HN, Lipton MJ, et al. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 1976;54:III107-17. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous